Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

The launch of the new Online Petition Center is part of the Department of Revenue’s efforts to improve online tools.

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

The Wisconsin Department of Revenue (DOR) stated on Tuesday that the option will be offered on Schedule 3, Part II of the ...

Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...

It seems the governor isn’t the only one trying to squeeze additional consumption tax dollars out of its beleaguered ...

The Dor Hadash Congregation of Pittsburgh issued a statement on Thursday regarding President Trump’s administration’s ...

Achalasia, a chronic oesophageal motility disorder, is defined by impaired lower oesophageal sphincter relaxation and absent peristalsis, leading to symptoms such as dysphagia and regurgitation.